Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
The 2025 American society of pediatric otolaryngology workforce and compensation survey: Current state and future directions.
International journal of pediatric otorhinolaryngology·2026
RCVS president reflects on the importance of service.
The Veterinary record·2026